The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sanger Sequencing Service Market Research Report 2024

Global Sanger Sequencing Service Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1735509

No of Pages : 107

Ask Your Query
Synopsis
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
The global Sanger Sequencing Service market was valued at US$ 213.6 million in 2023 and is anticipated to reach US$ 212.5 million by 2030, witnessing a CAGR of -0.2% during the forecast period 2024-2030.
Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.
This report aims to provide a comprehensive presentation of the global market for Sanger Sequencing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sanger Sequencing Service.
Report Scope
The Sanger Sequencing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sanger Sequencing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sanger Sequencing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
Segment by Type
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others
Segment by Application
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sanger Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sanger Sequencing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR Products
1.2.3 Plasmid DNA
1.2.4 Bacterial Artificial Chromosomes (BAC)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sanger Sequencing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institutions
1.3.3 Biotech Companies
1.3.4 Universities and Colleges
1.3.5 Hospitals and Clinics
1.3.6 Pharmaceutical Companies
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sanger Sequencing Service Market Perspective (2019-2030)
2.2 Sanger Sequencing Service Growth Trends by Region
2.2.1 Global Sanger Sequencing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sanger Sequencing Service Historic Market Size by Region (2019-2024)
2.2.3 Sanger Sequencing Service Forecasted Market Size by Region (2025-2030)
2.3 Sanger Sequencing Service Market Dynamics
2.3.1 Sanger Sequencing Service Industry Trends
2.3.2 Sanger Sequencing Service Market Drivers
2.3.3 Sanger Sequencing Service Market Challenges
2.3.4 Sanger Sequencing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sanger Sequencing Service Players by Revenue
3.1.1 Global Top Sanger Sequencing Service Players by Revenue (2019-2024)
3.1.2 Global Sanger Sequencing Service Revenue Market Share by Players (2019-2024)
3.2 Global Sanger Sequencing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sanger Sequencing Service Revenue
3.4 Global Sanger Sequencing Service Market Concentration Ratio
3.4.1 Global Sanger Sequencing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sanger Sequencing Service Revenue in 2023
3.5 Sanger Sequencing Service Key Players Head office and Area Served
3.6 Key Players Sanger Sequencing Service Product Solution and Service
3.7 Date of Enter into Sanger Sequencing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sanger Sequencing Service Breakdown Data by Type
4.1 Global Sanger Sequencing Service Historic Market Size by Type (2019-2024)
4.2 Global Sanger Sequencing Service Forecasted Market Size by Type (2025-2030)
5 Sanger Sequencing Service Breakdown Data by Application
5.1 Global Sanger Sequencing Service Historic Market Size by Application (2019-2024)
5.2 Global Sanger Sequencing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sanger Sequencing Service Market Size (2019-2030)
6.2 North America Sanger Sequencing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sanger Sequencing Service Market Size by Country (2019-2024)
6.4 North America Sanger Sequencing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sanger Sequencing Service Market Size (2019-2030)
7.2 Europe Sanger Sequencing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sanger Sequencing Service Market Size by Country (2019-2024)
7.4 Europe Sanger Sequencing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sanger Sequencing Service Market Size (2019-2030)
8.2 Asia-Pacific Sanger Sequencing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sanger Sequencing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Sanger Sequencing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sanger Sequencing Service Market Size (2019-2030)
9.2 Latin America Sanger Sequencing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sanger Sequencing Service Market Size by Country (2019-2024)
9.4 Latin America Sanger Sequencing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sanger Sequencing Service Market Size (2019-2030)
10.2 Middle East & Africa Sanger Sequencing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sanger Sequencing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Sanger Sequencing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Sanger Sequencing Service Introduction
11.1.4 Thermo Fisher Revenue in Sanger Sequencing Service Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Azenta
11.2.1 Azenta Company Detail
11.2.2 Azenta Business Overview
11.2.3 Azenta Sanger Sequencing Service Introduction
11.2.4 Azenta Revenue in Sanger Sequencing Service Business (2019-2024)
11.2.5 Azenta Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Detail
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Sanger Sequencing Service Introduction
11.3.4 Eurofins Scientific Revenue in Sanger Sequencing Service Business (2019-2024)
11.3.5 Eurofins Scientific Recent Development
11.4 LGC Biosearch Technologies
11.4.1 LGC Biosearch Technologies Company Detail
11.4.2 LGC Biosearch Technologies Business Overview
11.4.3 LGC Biosearch Technologies Sanger Sequencing Service Introduction
11.4.4 LGC Biosearch Technologies Revenue in Sanger Sequencing Service Business (2019-2024)
11.4.5 LGC Biosearch Technologies Recent Development
11.5 Fasteris
11.5.1 Fasteris Company Detail
11.5.2 Fasteris Business Overview
11.5.3 Fasteris Sanger Sequencing Service Introduction
11.5.4 Fasteris Revenue in Sanger Sequencing Service Business (2019-2024)
11.5.5 Fasteris Recent Development
11.6 QuintaraBio
11.6.1 QuintaraBio Company Detail
11.6.2 QuintaraBio Business Overview
11.6.3 QuintaraBio Sanger Sequencing Service Introduction
11.6.4 QuintaraBio Revenue in Sanger Sequencing Service Business (2019-2024)
11.6.5 QuintaraBio Recent Development
11.7 Laragen
11.7.1 Laragen Company Detail
11.7.2 Laragen Business Overview
11.7.3 Laragen Sanger Sequencing Service Introduction
11.7.4 Laragen Revenue in Sanger Sequencing Service Business (2019-2024)
11.7.5 Laragen Recent Development
11.8 Microsynth
11.8.1 Microsynth Company Detail
11.8.2 Microsynth Business Overview
11.8.3 Microsynth Sanger Sequencing Service Introduction
11.8.4 Microsynth Revenue in Sanger Sequencing Service Business (2019-2024)
11.8.5 Microsynth Recent Development
11.9 Nucleics
11.9.1 Nucleics Company Detail
11.9.2 Nucleics Business Overview
11.9.3 Nucleics Sanger Sequencing Service Introduction
11.9.4 Nucleics Revenue in Sanger Sequencing Service Business (2019-2024)
11.9.5 Nucleics Recent Development
11.10 GenScript Biotech
11.10.1 GenScript Biotech Company Detail
11.10.2 GenScript Biotech Business Overview
11.10.3 GenScript Biotech Sanger Sequencing Service Introduction
11.10.4 GenScript Biotech Revenue in Sanger Sequencing Service Business (2019-2024)
11.10.5 GenScript Biotech Recent Development
11.11 CeMIA
11.11.1 CeMIA Company Detail
11.11.2 CeMIA Business Overview
11.11.3 CeMIA Sanger Sequencing Service Introduction
11.11.4 CeMIA Revenue in Sanger Sequencing Service Business (2019-2024)
11.11.5 CeMIA Recent Development
11.12 StarSEQ
11.12.1 StarSEQ Company Detail
11.12.2 StarSEQ Business Overview
11.12.3 StarSEQ Sanger Sequencing Service Introduction
11.12.4 StarSEQ Revenue in Sanger Sequencing Service Business (2019-2024)
11.12.5 StarSEQ Recent Development
11.13 Source BioScience
11.13.1 Source BioScience Company Detail
11.13.2 Source BioScience Business Overview
11.13.3 Source BioScience Sanger Sequencing Service Introduction
11.13.4 Source BioScience Revenue in Sanger Sequencing Service Business (2019-2024)
11.13.5 Source BioScience Recent Development
11.14 Guangzhou Life Technologies DaAn
11.14.1 Guangzhou Life Technologies DaAn Company Detail
11.14.2 Guangzhou Life Technologies DaAn Business Overview
11.14.3 Guangzhou Life Technologies DaAn Sanger Sequencing Service Introduction
11.14.4 Guangzhou Life Technologies DaAn Revenue in Sanger Sequencing Service Business (2019-2024)
11.14.5 Guangzhou Life Technologies DaAn Recent Development
11.15 SciGenom Labs
11.15.1 SciGenom Labs Company Detail
11.15.2 SciGenom Labs Business Overview
11.15.3 SciGenom Labs Sanger Sequencing Service Introduction
11.15.4 SciGenom Labs Revenue in Sanger Sequencing Service Business (2019-2024)
11.15.5 SciGenom Labs Recent Development
11.16 Psomagen
11.16.1 Psomagen Company Detail
11.16.2 Psomagen Business Overview
11.16.3 Psomagen Sanger Sequencing Service Introduction
11.16.4 Psomagen Revenue in Sanger Sequencing Service Business (2019-2024)
11.16.5 Psomagen Recent Development
11.17 Tsingke Biotechnology
11.17.1 Tsingke Biotechnology Company Detail
11.17.2 Tsingke Biotechnology Business Overview
11.17.3 Tsingke Biotechnology Sanger Sequencing Service Introduction
11.17.4 Tsingke Biotechnology Revenue in Sanger Sequencing Service Business (2019-2024)
11.17.5 Tsingke Biotechnology Recent Development
11.18 GenHunter
11.18.1 GenHunter Company Detail
11.18.2 GenHunter Business Overview
11.18.3 GenHunter Sanger Sequencing Service Introduction
11.18.4 GenHunter Revenue in Sanger Sequencing Service Business (2019-2024)
11.18.5 GenHunter Recent Development
11.19 CD Genomics
11.19.1 CD Genomics Company Detail
11.19.2 CD Genomics Business Overview
11.19.3 CD Genomics Sanger Sequencing Service Introduction
11.19.4 CD Genomics Revenue in Sanger Sequencing Service Business (2019-2024)
11.19.5 CD Genomics Recent Development
11.20 Shanghai Personalbio Technology
11.20.1 Shanghai Personalbio Technology Company Detail
11.20.2 Shanghai Personalbio Technology Business Overview
11.20.3 Shanghai Personalbio Technology Sanger Sequencing Service Introduction
11.20.4 Shanghai Personalbio Technology Revenue in Sanger Sequencing Service Business (2019-2024)
11.20.5 Shanghai Personalbio Technology Recent Development
11.21 Suzhou Hongxun Biotechnologies
11.21.1 Suzhou Hongxun Biotechnologies Company Detail
11.21.2 Suzhou Hongxun Biotechnologies Business Overview
11.21.3 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Introduction
11.21.4 Suzhou Hongxun Biotechnologies Revenue in Sanger Sequencing Service Business (2019-2024)
11.21.5 Suzhou Hongxun Biotechnologies Recent Development
11.22 Guangzhou IGE Biotechnology
11.22.1 Guangzhou IGE Biotechnology Company Detail
11.22.2 Guangzhou IGE Biotechnology Business Overview
11.22.3 Guangzhou IGE Biotechnology Sanger Sequencing Service Introduction
11.22.4 Guangzhou IGE Biotechnology Revenue in Sanger Sequencing Service Business (2019-2024)
11.22.5 Guangzhou IGE Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock